FDA Accepts Supplement for VANTAS (Histrelin Acetate) by Endo Operations
The FDA has accepted a supplemental NDA for VANTAS, which contains the active ingredient histrelin acetate.
Asset / Drug
Drug and asset intelligence for VANTAS with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Hormonal Therapy
No catalysts indexed for this entity yet.
July 13, 2026 · N/A
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.